A hollow fiber ultrafiltration method for total IgE detection in forensic hemolysis samples

Through the combination of hollow fiber ultrafiltration technology and electrochemiluminescence method, the problem of total IgE detection failure caused by hemolysis interference in forensic anatomy is solved, and the accurate detection of forensic cadaver hemolysis samples is achieved, which improves the credibility and accuracy of the detection. .

CN110938139BActive Publication Date: 2024-11-08CHIMEDICAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202010064994.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2020-01-20
Publication Date
2024-11-08
Estimated Expiration
2040-01-20

AI Technical Summary

Technical Problem

In forensic anatomy, the blood of the cadaver is severely affected by hemolytic interference, which leads to the loss of credible value of the results of the detection of total IgE after death by conventional methods. The existing technology has not yet effectively solved this problem.

Method used

Using hollow fiber ultrafiltration technology combined with electrochemiluminescence method, the ultrafiltration membrane intercepts small molecular weight interference impurities and detects the total IgE in the ultrafilter solution, establish a linear regression equation to correct the ultrafilter, and realize the total IgE of the forensic cadaver hemolytic samples. Accurate detection.

Benefits of technology

It effectively removes the interfering impurities in the hemolytic samples, improves the accuracy and credibility of the detection, can objectively and accurately reflect the total IgE level in the unhemolytic samples, and solves the problem of hemolytic interference in post-death biochemical detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN110938139B_ABST
    Figure CN110938139B_ABST
Patent Text Reader

Abstract

The present invention relates to the field of detection technology, and in particular to a hollow fiber ultrafiltration combined with electrochemiluminescence technology to detect total IgE in forensic hemolysis samples. It includes a hollow fiber ultrafiltration component, a No. 1 syringe, a No. 2 syringe, a No. 3 syringe, a No. 4 syringe and a three-way reversing valve; the No. 1 syringe and the No. 2 syringe contain hemolysis samples to be processed, the No. 3 syringe contains physiological saline, and the No. 4 syringe is used to extract waste liquid; the No. 1 syringe and the No. 3 syringe are connected to one end of the hollow fiber ultrafiltration component through a three-way reversing valve, and the other end of the hollow fiber ultrafiltration component is respectively connected to the No. 2 syringe (connected to the inner core of the ultrafiltration component) and the No. 4 syringe (connected to the outer tube of the ultrafiltration component). It is the first time that the electrochemiluminescence method is applied to the detection of postmortem biochemical total IgE.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of detection technology, and in particular to a method for detecting total IgE in forensic hemolysis samples by using hollow fiber ultrafiltration combined with electrochemiluminescence technology. Background Art

[0002] Electrochemiluminescence, also known as electrochemiluminescence, is a luminescent phenomenon caused by electron transfer and accompanying chemical reactions between reactants on the electrode surface. This method is an important electrochemical and luminescent analysis method, widely used in biological immunoassays, medical diagnosis, food and environmental monitoring, and has become one of the important methods for in vitro diagnosis. As a detection method that has developed rapidly in recent years, electrochemiluminescence has the advantages of wide linear range, good repeatability, high precision, and good specificity compared with traditional detection methods. In addition, clinical studies have reported that electrochemiluminescence has a certain anti-interference ability against hemolysis, lipemia, jaundice, etc. when detecting hepatitis B surface antigen and troponin, but it has not yet been used in postmortem biochemical detection.

[0003] Postmortem biochemical detection of IgE has been widely used in forensic practice. However, in forensic autopsy, the blood of corpses is seriously interfered by hemolysis and serum cannot be separated. In clinical research, hemolysis has a significant interference on many detection indicators. In actual situations, the degree of hemolysis of postmortem samples is much more serious than that of clinical samples. In particular, the severe hemolysis caused by freezing of most postmortem corpses in my country makes the results of total IgE detection by conventional methods lose their credible value. Therefore, it is of great significance to establish an effective pretreatment method for IgE detection in hemolyzed samples for postmortem biochemical detection of total IgE in hemolyzed samples of forensic corpses. Summary of the invention

[0004] The present invention aims at the defects of the prior art and provides a hollow fiber ultrafiltration method for detecting total IgE in forensic hemolyzed samples, which can establish effective IgE detection in hemolyzed samples and is of great significance for post-mortem biochemical detection of total IgE in forensic corpse hemolyzed samples.

[0005] To achieve the above purpose, the present invention adopts a hollow fiber ultrafiltration device; including a hollow fiber ultrafiltration component, a No. 1 syringe, a No. 2 syringe, a No. 3 syringe, a No. 4 syringe and a three-way reversing valve.

[0006] The No. 1 syringe and the No. 2 syringe contain hemolysis samples to be processed, the No. 3 syringe contains physiological saline, and the No. 4 syringe is used to extract waste liquid.

[0007] The No. 1 syringe and the No. 3 syringe are connected to one end of the hollow fiber ultrafiltration component through a three-way reversing valve, and the other end of the hollow fiber ultrafiltration component is respectively connected to the No. 2 syringe (connected to the inner core of the ultrafiltration component) and the No. 4 syringe (connected to the outer tube of the ultrafiltration component).

[0008] Furthermore, the hollow fiber ultrafiltration component adopts MicroKros produced by Spectrum Laboratories, USA. ® C02-E100-05-N---Ultrafiltration component (the pore size of this component is 100 KD and the contact area is 20cm 2 ).

[0009] Furthermore, the three-way reversing valve is a two-position three-way reversing valve.

[0010] Furthermore, each end of the ultrafiltration component has a connector; the No. 2 syringe is connected to the inner tube of the ultrafiltration component through one of the connectors, the No. 4 syringe is connected to the outer tube of the ultrafiltration component through a connector, and the No. 1 syringe and the No. 3 syringe are connected to the ultrafiltration component through another connector.

[0011] A hollow fiber ultrafiltration method for detecting total IgE in forensic hemolysis samples comprises the following steps.

[0012] Step 1: Ultrafilter the whole hemolyzed sample using a hollow fiber ultrafiltration device for hemolyzed sample processing.

[0013] Step 2: After ultrafiltration, the liquid in the inner core of the ultrafiltration component is taken out and centrifuged to extract the supernatant as the ultrafiltrate.

[0014] Step 3: Detect IgE in the ultrafiltrate by electrochemiluminescence.

[0015] Step 4: A linear regression equation is established based on the total IgE in the serum and the total IgE in the ultrafiltrate when the corpse is not hemolyzed, and the IgE in the ultrafiltrate is corrected.

[0016] Step 5: Obtain the total IgE content of the forensic hemolysis sample.

[0017] Furthermore, step 1 includes the following steps.

[0018] Step 1.1. Use No. 1 syringe to extract 2 mL of the whole hemolyzed sample, adjust the three-way reversing valve, close the No. 3 syringe, and slowly push the No. 1 syringe until the entire hollow fiber ultrafiltration component core is filled with the sample. Note the scale value of the liquid in the No. 1 syringe at this time.

[0019] Step 1.2, adjust the three-way reversing valve, close the No. 1 syringe, open the No. 3 syringe, inject 0.5-1 ml of normal saline into the ultrafiltration component, then close the No. 3 syringe and open the No. 1 syringe, repeatedly push the No. 1 and No. 2 syringes to ultrafilter the liquid in the ultrafiltration component, use the No. 4 syringe to extract the waste liquid from the outer tube and discard it.

[0020] Step 1.3, repeat step 1.2 until the waste liquid in the outer tube of the ultrafiltration component is colorless. At this time, adjust the volume of the filtrate in the inner core of the ultrafiltration component until the liquid scale in the No. 1 syringe is the same as the scale value recorded in step 1.1 when the No. 2 syringe is emptied, and retain the inner core liquid.

[0021] Furthermore, in step 2, the supernatant is extracted by high-speed centrifugation at 12,000×g for 5 minutes as ultrafiltrate; the filtrate after ultrafiltration is light red. (The filtrate after ultrafiltration is lighter and clearer than the hemolyzed sample before ultrafiltration.) Figure 2 ).

[0022] Furthermore, the step 4 includes the following steps.

[0023] Step 4.1, take N samples for detecting the IgE concentration in the serum of the corpse before hemolysis by electrochemiluminescence method, and mark them as Y1, Y2, Y3, etc.

[0024] Step 4.2, and then use the electrochemiluminescence method to detect the IgE concentration in the ultrafiltrate, and mark them as X1, X2, X3, etc.

[0025] Step 4.3: Use SPSS software to perform statistical analysis on each group of X and Y values, and use the linear regression equation Y=αX+β to obtain the values ​​of coefficient α and coefficient β.

[0026] Step 4.4: Correct the IgE in the ultrafiltrate according to the coefficient α, coefficient β and linear regression equation.

[0027] Compared with the prior art, the present invention has beneficial effects.

[0028] The present invention adopts hollow fiber ultrafiltration technology for the first time to process hemolyzed samples. The small molecular weight interfering impurities of the hemolyzed samples are removed and the target indicators are retained through the physical pore size of the ultrafiltration membrane, thereby achieving good processing effects. A correction equation is established through anatomical samples of actual cases, which perfectly solves the influence of hemolytic factors on the postmortem biochemical detection of total IgE in actual forensic work.

[0029] The electrochemiluminescence method adopted in the present invention is a commonly used detection method in clinical tests at home and abroad. It has good anti-interference ability to interference factors such as hemolysis, and can objectively and accurately detect the total IgE in the ultrafiltrate. In the international forensic medicine field, this is the first time that the electrochemiluminescence method is proposed to be used for the postmortem biochemical detection of total IgE, and it is also the first time that the hollow fiber ultrafiltration technology is combined with the electrochemiluminescence method for the postmortem biochemical detection of total IgE in forensic corpse hemolysis samples. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] The present invention is further described below in conjunction with the accompanying drawings and specific implementation methods. The protection scope of the present invention is not limited to the following description.

[0031] Figure 1 It is a schematic diagram of the overall structure of the present invention.

[0032] Figure 2 Schematic diagram of the properties of whole blood and ultrafiltrate.

[0033] Figure 3 Linear regression plot of ultrafiltrate and serum total IgE detection values.

[0034] Figure 4 Table 1 is the detection value of total IgE in ultrafiltrate and original serum using electrochemiluminescence technology.

[0035] In the figure, 1 is a No. 1 syringe, 2 is a No. 2 syringe, 3 is a No. 3 syringe, 4 is a No. 4 syringe, 5 is an ultrafiltration component, and 6 is a three-way reversing valve. DETAILED DESCRIPTION

[0036] Ultrafiltration refers to the technology of using ultrafiltration membrane with fixed pore size to separate and purify substances of different molecular weight in liquid by different pressures on both sides of the membrane. It is widely used in industrial water purification and wastewater treatment, and protein separation and purification. In this method, we selected a tangential flow hollow fiber ultrafiltration membrane column with an appropriate pore size of 100 KD to ultrafilter the hemolyzed sample, which can not only retain the large molecular weight IgE (relative molecular mass 196000), but also effectively remove the hemoglobin (relative molecular mass 64000) and other small molecular weight impurities that produce color interference, and detect the total IgE of the ultrafiltrate by electrochemiluminescence. By correcting with the established correction equation, the total serum IgE level before hemolysis can be restored to a large extent.

[0037] like Figure 1-2 As shown, the present invention includes a hollow fiber ultrafiltration component, a No. 1 syringe, a No. 2 syringe, a No. 3 syringe, a No. 4 syringe and a three-way reversing valve.

[0038] The No. 1 syringe and the No. 2 syringe contain hemolyzed samples, the No. 3 syringe contains physiological saline, and the No. 4 syringe is used to extract waste liquid.

[0039] The No. 1 syringe and the No. 3 syringe are connected to one end of the hollow fiber ultrafiltration component through a three-way reversing valve, and the other end of the hollow fiber ultrafiltration component is respectively connected to the No. 2 syringe (connected to the inner core of the ultrafiltration component) and the No. 4 syringe (connected to the outer tube of the ultrafiltration component).

[0040] Furthermore, the hollow fiber ultrafiltration component adopts MicroKros produced by Spectrum Laboratories, USA. ® C02-E100-05-N---Ultrafiltration component. The pore size of this component is 100 KD and the contact area is 20cm 2 .

[0041] The through-hole fiber ultrafiltration component comprises an inner tube (with a pore size) and an outer tube, wherein the inner tube contains the liquid to be ultrafiltered and the outer tube contains the waste liquid.

[0042] Furthermore, the three-way reversing valve is a two-position three-way reversing valve.

[0043] Furthermore, each end of the ultrafiltration component has a connector; the No. 2 syringe is connected to the inner tube of the ultrafiltration component through one of the connectors, the No. 4 syringe is connected to the outer tube of the ultrafiltration component through a connector, and the No. 1 syringe and the No. 3 syringe are connected to the ultrafiltration component through another connector.

[0044] A hollow fiber ultrafiltration method for detecting total IgE in forensic hemolysis samples comprises the following steps.

[0045] Step 1: Ultrafilter the whole hemolyzed sample to be processed using a hollow fiber ultrafiltration device for hemolyzed sample processing.

[0046] Step 2: After ultrafiltration, the liquid in the inner core of the ultrafiltration component is taken out and centrifuged to extract the supernatant as the ultrafiltrate.

[0047] Step 3: Detect IgE in the ultrafiltrate by electrochemiluminescence.

[0048] Step 4: A linear regression equation is established based on the total IgE in the serum and the total IgE in the ultrafiltrate when the corpse is not hemolyzed, and the IgE in the ultrafiltrate is corrected.

[0049] Step 5: Obtain the total IgE content of the forensic hemolysis sample.

[0050] Furthermore, step 1 includes the following steps.

[0051] Step 1.1. Use No. 1 syringe to extract 2 mL of the whole hemolyzed sample, adjust the three-way reversing valve, close the No. 3 syringe, and slowly push the No. 1 syringe until the entire hollow fiber ultrafiltration component core is filled with the sample. Note the scale value of the liquid in the No. 1 syringe at this time.

[0052] Step 1.2, adjust the three-way reversing valve, close the No. 1 syringe, open the No. 3 syringe, inject 0.5-1 ml of normal saline into the ultrafiltration component, then close the No. 3 syringe and open the No. 1 syringe, repeatedly push the No. 1 and No. 2 syringes to ultrafilter the liquid in the ultrafiltration component, use the No. 4 syringe to extract the waste liquid from the outer tube and discard it.

[0053] Step 1.3, repeat step 1.2 until the waste liquid in the outer tube of the ultrafiltration component is colorless. At this time, adjust the volume of the filtrate in the inner core of the ultrafiltration component until the liquid scale in the No. 1 syringe is the same as the scale value recorded in step 1.1 when the No. 2 syringe is emptied, and retain the inner core liquid.

[0054] Furthermore, in step 2, the supernatant is extracted by high-speed centrifugation at 12,000×g for 5 minutes as ultrafiltrate; the filtrate after ultrafiltration is light red. The filtrate after ultrafiltration is lighter and clearer than the hemolyzed sample before ultrafiltration ( Figure 2 ).

[0055] Furthermore, the step 4 includes the following steps.

[0056] Step 4.1, take N samples for detecting the IgE concentration in the serum of the corpse before hemolysis by electrochemiluminescence method, and mark them as Y1, Y2, Y3, etc.

[0057] Step 4.2, and then use the electrochemiluminescence method to detect the IgE concentration in the ultrafiltrate, and mark them as X1, X2, X3, etc.

[0058] Step 4.3: Use SPSS software to perform statistical analysis on each group of X and Y values, and use the linear regression equation Y=αX+β to obtain the values ​​of coefficient α and coefficient β.

[0059] Step 4.4: Correct the IgE in the ultrafiltrate according to the coefficient α, coefficient β and linear regression equation.

[0060] As a specific example of the calibration process, 33 non-frozen autopsy cardiac blood samples were used. The cardiac blood samples were repeatedly frozen and thawed three times to cause complete hemolysis of the cardiac blood samples. Ultrafiltration was performed using the ultrafiltration method described in the present invention, and the total IgE in the ultrafiltrate and the original serum was detected using electrochemiluminescence technology (detection values ​​are shown in Figure 4 Table 1), the correlation analysis of the detection values ​​of total IgE in ultrafiltrate and serum was performed, and a good correlation was obtained (correlation coefficient r = 0.984) ( Figure 3) and established the correction equation for ultrafiltrate and total serum IgE: IgE concentration in ultrafiltrate (X) and IgE concentration in non-hemolyzed serum (Y) Y=3.0593X + 2.0173.

[0061] The corrected IgE value can more realistically reflect the true value of the serum before hemolysis of the unhemolyzed sample. For example, we used this ultrafiltration technology to process the hemolyzed sample, and detected the IgE concentration in the ultrafiltrate by electrochemiluminescence method, which was (X value) 15.5 IU / mL. After substituting it into the correction formula, it can be inferred that the IgE concentration in the serum (Y value) is about 49.44 IU / mL.

[0062] It can be understood that the above specific description of the present invention is only used to illustrate the present invention and is not limited to the technical solutions described in the embodiments of the present invention. Those skilled in the art should understand that the present invention can still be modified or replaced by equivalents to achieve the same technical effects; as long as the use requirements are met, they are within the protection scope of the present invention.

Claims

1. A hollow fiber ultrafiltration method for detecting total IgE in forensic hemolysis samples, comprising: A hollow fiber ultrafiltration device; characterized in that the hollow fiber ultrafiltration device comprises a hollow fiber ultrafiltration component, a No. 1 syringe, a No. 2 syringe, a No. 3 syringe, a No. 4 syringe and a three-way reversing valve; characterized in that the No. 1 syringe and the No. 2 syringe contain hemolyzed samples to be processed, the No. 3 syringe contains physiological saline, and the No. 4 syringe is used to extract waste liquid; The No. 1 syringe and the No. 3 syringe are connected to one end of the hollow fiber ultrafiltration component through a three-way reversing valve, and the other end of the hollow fiber ultrafiltration component is connected to the No. 2 syringe and the No. 4 syringe respectively; The hollow fiber ultrafiltration method comprises the following steps: Step 1, ultrafiltration of the whole hemolyzed sample using a hollow fiber ultrafiltration device for hemolyzed sample processing; Step 2, after ultrafiltration, the liquid in the inner core of the ultrafiltration component is taken out and centrifuged to extract the supernatant as the ultrafiltrate; Step 3, detecting IgE in the ultrafiltrate by electrochemiluminescence; Step 4, establishing a linear regression equation based on the total IgE in the serum and the total IgE in the ultrafiltrate when the corpse is not hemolyzed, and correcting the IgE in the ultrafiltrate; Step 5, obtaining the total IgE content of the forensic hemolysis sample; The step 4 comprises the following steps: Step 4.1, taking N samples for detecting the IgE concentration in the serum of the corpse without hemolysis by electrochemiluminescence method, and marking them as Y1, Y2, Y3, etc.; Step 4.2, then take the corresponding samples and use electrochemiluminescence method to detect the IgE concentration in the ultrafiltrate, and mark them as X1, X2, X3, etc.; Step 4.3, use SPSS software to perform statistical analysis on each group of X and Y values, and use the linear regression equation Y=αX+β to obtain the value of coefficient α and coefficient β; Step 4.4, correcting the IgE in the ultrafiltrate according to the coefficient α, the coefficient β and the linear regression equation; The hollow fiber ultrafiltration component adopts MicroKros produced by Spectrum Laboratories, USA ® C02-E100-05-N --- Ultrafiltration component model; The three-way reversing valve is a two-position three-way reversing valve; The two ends of the ultrafiltration component each have a connector; the No. 2 syringe is connected to the inner tube of the ultrafiltration component via one of the connectors, the No. 4 syringe is connected to the outer tube of the ultrafiltration component via the connector, and the No. 1 syringe and the No. 3 syringe are connected to the ultrafiltration component via another connector; The step 1 includes the following steps: Step 1.1, use syringe No. 1 to extract 2 mL of the whole hemolyzed sample, adjust the three-way reversing valve, close syringe No. 3, slowly push syringe No. 1 until the entire hollow fiber ultrafiltration component core is filled with the sample, and record the scale value of the liquid in syringe No. 1 at this time; Step 1.2, adjust the three-way reversing valve, close the No. 1 syringe, open the No. 3 syringe, inject 0.5-1 ml of normal saline into the ultrafiltration component, close the No. 3 syringe, open the No. 1 syringe, repeatedly push the No. 1 and No. 2 syringes to ultrafilter the liquid in the ultrafiltration component, use the No. 4 syringe to extract the waste liquid from the outer tube and discard it; Step 1.3, repeat step 1.2 until the waste liquid in the outer tube of the ultrafiltration component is colorless, and then adjust the volume of the filtrate in the inner core of the ultrafiltration component until the liquid scale in the No. 1 syringe is the same as the scale value recorded in step 1.1 when the No. 2 syringe is emptied, and retain the inner core liquid; In the step 2, a high-speed centrifuge is used to extract the supernatant at 12,000×g for 5 minutes to obtain an ultrafiltrate; the filtrate after ultrafiltration is light red.